The value of patient-reported outcomes in early-phase clinical trials

被引：34

作者：

Retzer, Ameeta ^{[1
,2
]}

Aiyegbusi, Olalekan Lee ^{[1
,2
,3
,4
]}

Rowe, Anna ^{[3
,5
]}

Newsome, Philip N. ^{[3
,6
]}

Douglas-Pugh, Jessica ^{[5
]}

Khan, Sheeba ^{[3
,6
,7
]}

Mittal, Saloni ^{[8
]}

Wilson, Roger ^{[9
]}

O'Connor, Daniel ^{[10
]}

Campbell, Lisa ^{[10
]}

Mitchell, Sandra A. ^{[11
]}

Calvert, Melanie ^{[1
,2
,3
,4
,12
,13
]}

机构：

[1] Univ Birmingham, Inst Appl Hlth Res, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England

[2] Univ Birmingham, Appl Res Ctr West Midlands, Natl Inst Hlth Res, Birmingham, W Midlands, England

[3] Univ Hosp Birmingham NHS Fdn Trust, Birmingham Biomed Res Ctr, Natl Inst Hlth Res, Birmingham, W Midlands, England

[4] Birmingham Hlth Partners Ctr Regulatory Sci & Inn, Birmingham, W Midlands, England

[5] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England

[6] Univ Birmingham, Inst Immunol & Immunotherapy, Ctr Liver & Gastrointestinal Res, Birmingham, W Midlands, England

[7] Univ Hosp Birmingham NHS Fdn Trust, Liver Unit, Birmingham, W Midlands, England

[8] Univ Birmingham, Birmingham, W Midlands, England

[9] NCRI Consumer Forum Natl Canc Res Inst, London, England

[10] Med & Healthcare Prod Regulatory Agcy MHRA, London, England

[11] NIH, Outcomes Res Branch, Div Canc Control & Populat Sci, Rockville, MD USA

[12] Univ Birmingham, Surg Reconstruct & Microbiol Res Ctr, Natl Inst Hlth Res, Birmingham, W Midlands, England

[13] Univ Birmingham, UK SPINE, Birmingham, W Midlands, England

来源：

NATURE MEDICINE | 2022年 / 28卷 / 01期

基金：

“创新英国”项目; 英国科研创新办公室;

关键词：

VALIDITY;

D O I：

10.1038/s41591-021-01648-4

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

If used correctly, patient-reported outcomes can provide preliminary evidence of efficacy and tolerability from a patient perspective, as well as supporting regulatory review.

引用

页码：18 / 20

页数：3

共 23 条

[1]

[Anonymous], 2018, J PATIENT REP OUTCOM, V2, P58

[2] Patient-reported outcome measurement in drug discovery: a tool to improve accuracy and completeness of efficacy and safety data [J].

Basch, Ethan ;

Dueck, Amylou C. .

EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (08) :753-758

[3] Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes [J].

Basch, Ethan ;

Jia, Xiaoyu ;

Heller, Glenn ;

Barz, Allison ;

Sit, Laura ;

Fruscione, Michael ;

Appawu, Mark ;

Iasonos, Alexia ;

Atkinson, Thomas ;

Goldfarb, Shari ;

Culkin, Ann ;

Kris, Mark G. ;

Schrag, Deborah .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (23) :1624-1632

[4] Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols The SPIRIT-PRO Extension [J].

Calvert, Melanie ;

Kyte, Derek ;

Mercieca-Bebber, Rebecca ;

Slade, Anita ;

Chan, An-Wen ;

King, Madeleine T. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (05) :483-494

[5] Enhancing the incorporation of the patient’s voice in drug development and evaluation [J].

Meghana Chalasani ;

Pujita Vaidya ;

Theresa Mullin .

Research Involvement and Engagement, 4 (1)

[6]

Chen AP, 2018, NOVEL DESIGNS OF EARLY PHASE TRIALS FOR CANCER THERAPEUTICS, P193, DOI 10.1016/B978-0-12-812512-0.00013-0

[7] The Use of Patient-Reported Outcome Measures in Phase I Oncology Clinical Trials [J].

Coleman, Robert L. ;

Beck, J. Thaddeus ;

Baranda, Joaquina C. ;

Jacobs, Ira ;

Smoyer, Karen E. ;

Lee, Lauren J. ;

Askerova, Zemfira ;

McGinnis, Justin ;

Ganti, Apar Kishor .

ONCOLOGY, 2021, :444-453

[8] Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) [J].

Dueck, Amylou C. ;

Mendoza, Tito R. ;

Mitchell, Sandra A. ;

Reeve, Bryce B. ;

Castro, Kathleen M. ;

Rogak, Lauren J. ;

Atkinson, Thomas M. ;

Bennett, Antonia V. ;

Denicoff, Andrea M. ;

O'Mara, Ann M. ;

Li, Yuelin ;

Clauser, Steven B. ;

Bryant, Donna M. ;

Bearden, James D., III ;

Gillis, Theresa A. ;

Harness, Jay K. ;

Siegel, Robert D. ;

Paul, Diane B. ;

Cleeland, Charles S. ;

Schrag, Deborah ;

Sloan, Jeff A. ;

Abernethy, Amy P. ;

Bruner, Deborah W. ;

Minasian, Lori M. ;

Basch, Ethan .

JAMA ONCOLOGY, 2015, 1 (08) :1051-1059

[9]

FDA, 2021, Core patient-reported outcomes in cancer clinical trials

[10]

FDA, 2009, GUIDANCE IND PATIENT

← 1 2 3 →